Fig 2: Kaplan-Meier survival curves of different prognostic factor: A - Age-categorical, B - Edema, C - Karnofsky Performance Status (KPS), D - Extent of resection, E - Corpus callosum involvement, F - IHC expression of P53, G - IHC expression of HIF-1alpha, H - IHC expression of TERT.

Fig 3: Characterization of PGCC from prostate cancer patients by Giemsa staining and ICC. Left panels correspond to Giemsa staining, while middle panels show the same cells after ICC. (a) multinucleated PGCC expressing AMACR; (b) mononucleated PGCC in EMT, positive to epithelial (brown) and vimentin (pink) markers; (c) multinucleated PGCC strongly positive to TERT (nuclear and cytoplasmic positivity); (d) multinucleated PGCC strongly expressing PSMA (pink) marker; (e) mononucleated PGCC expressing the macrophage marker CD68 (brown) with strong PSMA expression (pink). Visualization system: DAB (brown) and permanent-red (pink).